Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
- Title
- Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
- Abstract
-
The use of nanotechnology has the potential to revolutionize the detection and treatment of cancer. Developments in protein engineering and materials science have led to the emergence of new nanoscale targeting techniques, which offer renewed hope for cancer patients. While several nanocarriers for medicinal purposes have been approved for human trials, only a few have been authorized for clinical use in targeting cancer cells. In this review, we analyze some of the authorized formulations and discuss the challenges of translating findings from the lab to the clinic. This study highlights the various nanocarriers and compounds that can be used for selective tumor targeting and the inherent difficulties in cancer therapy. Nanotechnology provides a promising platform for improving cancer detection and treatment in the future, but further research is needed to overcome the current limitations in clinical translation.
- Scientific Type
- غير معروف
- Journal volume
- vol.22,No.1
- Collaboration type
- مشترك
- Publish Date
- October 9, 2023
- Participated Universities (Publication)
-
Alnoor University
- Scopus status
- In Scopus
- Scopus index year
- 2 023
- Scopus quarter
- 1
- Scopus citation score
- 52.5
- Clarivate status
- In Clarivate
- Clarivate index year
- 2 023
- Clarivate impafact
- 41.44400024
- Pub. Med. status
- In PubMed
- Author (Publication)
-
عمر قتيبة بدر الدين محمود
- Journal (Publication)
- Molecular Cancer
- Publisher (Publication)
-
Springer Nature
- ISSN
- 1476-4598
- Country (Publication)
-
United kingdom
- Country type
- عالمية
- College (Publication)
-
College of Pharmacy
- Departement (Publication)
-
Department of Pharmacy
- Media
-
Academic paper
